Chemestmed

Traditional drug development focuses on directly targeting disease-causing proteins. In recent years, a new approach has rapidly emerged – one based on regulating cellular processes at the RNA level. The underlying field of research, known as epitranscriptomics, studies chemical modifications to RNA, their purpose and destiny in cells. This approach has the potential to redefine how many diseases are treated, as it can target previously undruggable pathways. These treatments are also expected...